?:authorAffiliation
|
-
[\'Department of Infectious Diseases, School of Immunology & Microbial Sciences, King\'s College London, London, UK.\', \'Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King\'s College London, London, UK.\', \'Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King\'s College London, London, UK; The Francis Crick Institute, UK.\', \'Division of Infection and Immunity, University College London, London, UK.\', \'Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Netherlands.\', \'Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.\', \'The Francis Crick Institute, UK.\', \'Department of Infectious Diseases, School of Immunology & Microbial Sciences, King\'s College London, London, UK; Genotype-to-Phenotype UK National Virology Consortium.\', \'Department of Infectious Diseases, School of Immunology & Microbial Sciences, King\'s College London, London, UK; Genotype-to-Phenotype UK National Virology Consortium. Electronic address: katie.doores@kcl.ac.uk.\']
|